163 related articles for article (PubMed ID: 35717621)
1. Risk factors for oral mucositis during chemotherapy treatment for solid tumors: a retrospective STROBE-guided study.
Martins JO; Borges MM; Malta CE; Carlos AC; Crispim AA; Moura JF; Fernandes-Lima IJ; Silva PG
Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e319-e329. PubMed ID: 35717621
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for dysgeusia during chemotherapy for solid tumors: a retrospective cross-sectional study.
Malta CEN; de Lima Martins JO; Carlos ACAM; Freitas MO; Magalhães IA; de Vasconcelos HCA; de Lima Silva-Fernandes IJ; de Barros Silva PG
Support Care Cancer; 2022 Jan; 30(1):313-325. PubMed ID: 34283319
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for oral mucositis in patients with solid tumors under treatment with cetuximab: a retrospective cross-sectional study.
Martins JO; Borges MM; Malta CE; Guerra JM; Crispim AA; Coelho BC; Silva LF; Silva PG
Med Oral Patol Oral Cir Bucal; 2024 Mar; 29(2):e248-e254. PubMed ID: 37992137
[TBL] [Abstract][Full Text] [Related]
4. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
5. Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial.
Kia SJ; Basirat M; Saedi HS; Arab SA
BMC Complement Med Ther; 2021 Sep; 21(1):232. PubMed ID: 34521398
[TBL] [Abstract][Full Text] [Related]
6. Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study).
Mañas A; Palacios A; Contreras J; Sánchez-Magro I; Blanco P; Fernández-Pérez C
Clin Transl Oncol; 2009 Oct; 11(10):669-76. PubMed ID: 19828409
[TBL] [Abstract][Full Text] [Related]
7. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy.
Curra M; Gabriel AF; Ferreira MBC; Martins MAT; Brunetto AT; Gregianin LJ; Martins MD
Support Care Cancer; 2021 Nov; 29(11):6243-6251. PubMed ID: 33846825
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for oral mucositis in patients with malignant tumors: a prospective cohort study.
Chen X; Yao L; Shan Q; Qian X; Lu X; Tang X; Chen S; Yu W
Ann Palliat Med; 2021 Jul; 10(7):8180-8189. PubMed ID: 34353102
[TBL] [Abstract][Full Text] [Related]
10. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
Chung YL; Pui NNM
Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
[TBL] [Abstract][Full Text] [Related]
13. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
[TBL] [Abstract][Full Text] [Related]
14. Severe oral mucositis relating to pain and worse oral condition among patients with solid tumors undergoing treatment with FOLFIRI and 5-FU: a retrospective study.
Almeida LC; Orcina BDF; Maciel AP; Santos DD; Manzano BR; Santos PSDS
Sao Paulo Med J; 2022; 140(4):588-594. PubMed ID: 35946677
[TBL] [Abstract][Full Text] [Related]
15. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
Reyes-Gibby CC; Wang J; Zhang L; Peterson CB; Do KA; Jenq RR; Shelburne S; Shah DP; Chambers MS; Hanna EY; Yeung SJ; Shete S
Cancer; 2020 Dec; 126(23):5124-5136. PubMed ID: 32888342
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas.
Nishimura N; Nakano K; Ueda K; Kodaira M; Yamada S; Mishima Y; Yokoyama M; Terui Y; Takahashi S; Hatake K
Support Care Cancer; 2012 Sep; 20(9):2053-9. PubMed ID: 22116139
[TBL] [Abstract][Full Text] [Related]
17. Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies.
Goldberg SL; Chiang L; Selina N; Hamarman S
Support Care Cancer; 2004 Jul; 12(7):526-30. PubMed ID: 15150704
[TBL] [Abstract][Full Text] [Related]
18. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases.
Raber-Durlacher JE; Weijl NI; Abu Saris M; de Koning B; Zwinderman AH; Osanto S
Support Care Cancer; 2000 Sep; 8(5):366-71. PubMed ID: 10975685
[TBL] [Abstract][Full Text] [Related]
19. Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer.
Kubota K; Kobayashi W; Sakaki H; Nakagawa H; Kon T; Mimura M; Ito R; Furudate K; Kimura H
Support Care Cancer; 2015 Nov; 23(11):3323-9. PubMed ID: 25987235
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
